학술논문

Carfilzomib in Combination with Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin (KDCEP) for the Treatment of Relapsed/Refractory Aggressive Plasma Cell Dyscrasias
Document Type
Journal
Source
BLOOD; NOV 2 2023, 142 3p. Supplement: 1
Subject
Language
English
ISSN
15280020